Enanta Pharmaceuticals
ENTA
#7729
Rank
NZ$0.74 B
Marketcap
NZ$25.69
Share price
3.64%
Change (1 day)
107.04%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.10 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total debt is NZ$0.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Enanta Pharmaceuticals - Total debt on balance sheet (from 2014 to 2025)

Total debt by year

Year Total debt Change
2025-09-30NZ$99.9 M14.29%
2024-09-30NZ$87.41 M97.66%
2023-09-30NZ$44.22 M-1.32%
2022-09-30NZ$44.81 M480.03%
2021-09-30NZ$7.72 M-36.82%
2020-09-30NZ$12.22 M3729.08%
2019-09-30NZ$0.31 M-27.8%
2018-09-30NZ$0.44 M-16.06%
2017-09-30NZ$0.52 M-27.95%
2016-09-30NZ$0.73 M-21.86%
2015-09-30NZ$0.93 M
2014-09-30N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$97.35 B 94,863.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$83.21 B 81,066.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$129.00 B 125,727.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$3.51 B 3,330.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$86.96 B 84,726.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$82.20 B 80,082.37%๐Ÿ‡บ๐Ÿ‡ธ USA